MPV-1440 |
DEXMEDETOMIDINE |
PRECEDEX |
MPV 1440 |
DEXMEDETOMIDINA |
(+)-MEDETOMIDINE |
DEXMÉDÉTOMIDINE |
DEXMEDETOMIDINUM |
DEXMEDETOMIDIN |
(+)-4-((S)-ALPHA,2,3-TRIMETHYLBENZYL)IMIDAZOLE |
(S)-MEDETOMIDINE |
PRECEDEX® |
chembl:CHEMBL778 |
pubchem.compound:5311068 |
chemidplus:113775-47-6 |
drugbank:00633 |
rxcui:48937 |
Year of Approval | 1999 |
Drug Class | hypnotics and sedatives |
Drug Class | analgesics |
FDA Approval | 1999 |
Drug Class | small molecule |
Drug Indications | Hypnotics and Sedatives |
Drug Indications | Analgesics |
Drug Categories | agents producing tachycardia |
Drug Categories | agents that produce hypertension |
Drug Categories | anesthetics |
Drug Categories | anesthetics, general |
Drug Categories | central alpha-2 adrenergic agonist |
Drug Categories | cytochrome p-450 cyp1a2 inhibitors (strength unknown) |
Drug Categories | cytochrome p-450 cyp2d6 inhibitors (strength unknown) |
Drug Categories | cytochrome p-450 enzyme inhibitors |
Drug Categories | cytochrome p-450 substrates |
Drug Categories | drugs that are mainly renally excreted |
Drug Categories | miscellaneous anxiolytics sedatives and hypnotics |
agonist (activating) |
Trial Name | - |
Novel drug target | Established target |
Specific Action of the Ligand | Partial agonist |
agonist (activating) |
Specific Action of the Ligand | Full agonist |
Endogenous Drug? | False |
Direct Interaction? | True |
agonist (activating) |
Specific Action of the Ligand | Full agonist |
Endogenous Drug? | False |
Direct Interaction? | True |
DEXMEDETOMIDINE | DrugBank Drug Name |
113775-47-6 | CAS Number |
Dexdor | Drug Brand |
Drug Type | small molecule |
Drug Groups | approved |
Drug Groups | vet_approved |
DEXMEDETOMIDINE | Primary Drug Name |
Drug Class | analgesics |
Drug Class | hypnotics and sedatives |
Year of Approval | 1999 |
Drug Indications | Analgesics |
Drug Indications | Hypnotics and Sedatives |
Drug Class | small molecule |
CHEMBL778 | ChEMBL Drug ID |
D0U3DU | TTD Drug ID |
DEXMEDETOMIDINE | GuideToPharmacology Ligand Name |